Birgit Lindeløv

758 total citations
10 papers, 149 citations indexed

About

Birgit Lindeløv is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Birgit Lindeløv has authored 10 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Otorhinolaryngology, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in Birgit Lindeløv's work include Head and Neck Cancer Studies (7 papers), Ear and Head Tumors (3 papers) and Testicular diseases and treatments (2 papers). Birgit Lindeløv is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Ear and Head Tumors (3 papers) and Testicular diseases and treatments (2 papers). Birgit Lindeløv collaborates with scholars based in Denmark. Birgit Lindeløv's co-authors include Hanne Sand Hansen, Jens Overgaard, Karsten Juhl Jørgensen, A Berthelsen, Bente Rasmusson, Marie Overgaard, Mikael Rørth, H Brincker, Henrik Schultz and B Nørgaard‐Pedersen and has published in prestigious journals such as Annals of the New York Academy of Sciences, Radiotherapy and Oncology and Acta Oncologica.

In The Last Decade

Birgit Lindeløv

10 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Lindeløv Denmark 5 55 48 44 39 33 10 149
Xiao Hu China 9 72 1.3× 118 2.5× 127 2.9× 77 2.0× 11 0.3× 33 267
E Siracká Slovakia 7 9 0.2× 45 0.9× 40 0.9× 65 1.7× 11 0.3× 21 197
Heitetsu Sai Japan 8 157 2.9× 154 3.2× 31 0.7× 58 1.5× 11 0.3× 13 311
Mariela Blum‐Murphy United States 6 74 1.3× 102 2.1× 140 3.2× 30 0.8× 10 0.3× 9 242
Xiaoqing Xu China 12 53 1.0× 67 1.4× 126 2.9× 105 2.7× 7 0.2× 28 298
Riena P. Aliredjo Netherlands 6 52 0.9× 114 2.4× 49 1.1× 60 1.5× 4 0.1× 9 272
Noel Chia Australia 7 54 1.0× 46 1.0× 201 4.6× 37 0.9× 45 1.4× 10 282
Lorenza Marino Italy 10 43 0.8× 78 1.6× 81 1.8× 26 0.7× 7 0.2× 18 216
Christoph Oehler‐Jänne Switzerland 9 159 2.9× 61 1.3× 133 3.0× 95 2.4× 5 0.2× 11 331
Carla Marani Italy 8 17 0.3× 20 0.4× 22 0.5× 23 0.6× 10 0.3× 19 135

Countries citing papers authored by Birgit Lindeløv

Since Specialization
Citations

This map shows the geographic impact of Birgit Lindeløv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Lindeløv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Lindeløv more than expected).

Fields of papers citing papers by Birgit Lindeløv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Lindeløv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Lindeløv. The network helps show where Birgit Lindeløv may publish in the future.

Co-authorship network of co-authors of Birgit Lindeløv

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Lindeløv. A scholar is included among the top collaborators of Birgit Lindeløv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Lindeløv. Birgit Lindeløv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vestermark, Lene Weber, et al.. (2008). A phase II study of thalidomide in patients with brain metastases from malignant melanoma. Acta Oncologica. 47(8). 1526–1530. 14 indexed citations
2.
Serup‐Hansen, Eva, et al.. (2006). A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer. Acta Oncologica. 46(3). 374–377. 1 indexed citations
3.
Lindeløv, Birgit & Hanne Sand Hansen. (1995). The Impact Of Lymph Node Metastases On The Results Of Treatment By Primary Radiotherapy And Secondary Surgery In Oropharyngeal Cancer. Acta Oncologica. 34(7). 965–968. 3 indexed citations
4.
Lindeløv, Birgit, et al.. (1992). Squamous Cell Carcinoma of the Oropharynx: Results of primary radiotherapy. Acta Oncologica. 31(3). 341–345. 6 indexed citations
5.
Overgaard, Jens, Hanne Sand Hansen, Birgit Lindeløv, et al.. (1991). Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiotherapy and Oncology. 20. 143–149. 68 indexed citations
6.
Lindeløv, Birgit & Harald S. Hansen. (1990). Advanced Squamous Cell Carcinoma of the Larynx. Acta Oncologica. 29(4). 505–508. 2 indexed citations
7.
Lindeløv, Birgit & HH Hansen. (1989). The Effect of Sequential Methotrexate and 5-Fluorouracil in Patients with Recurrent Head and Neck Cancer. Acta Oncologica. 28(2). 227–230. 4 indexed citations
8.
Kirkegaard, Jørgen, Birgit Lindeløv, & P. Bretlau. (1989). Traditional and new treatment strategies for oral squamous cell carcinomas.. PubMed. 68(8). 592–4, 600. 3 indexed citations
9.
Nørgaard‐Pedersen, B, Henrik Schultz, H Brincker, et al.. (1984). Tumour Markers in Testicular Germ Cell Tumours Five-Year Experience from the DATECA Study 1976–1980. Acta Radiologica Oncology. 23(4). 287–294. 44 indexed citations
10.
Nørgaard‐Pedersen, B, Henrik Schultz, H Brincker, et al.. (1983). BIOCHEMICAL MARKERS FOR TESTICULAR GERMCELL TUMORS IN RELATION TO HISTOLOGY AND STAGE: SOME EXPERIENCES FROM THE DANISH TESTICULAR CANCER (DATECA) STUDY FROM 1976 THROUGH 1981a. Annals of the New York Academy of Sciences. 417(1). 390–399. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026